J. Perel

Mark D. Miller, B. Pollock, C. Reynolds, 1996, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Clinical implications of imipramine plasma levels for depressive illness.

J. Fleiss, A. Glassman, J. Perel, 1977, Archives of general psychiatry.

Bupropion for attentiondeficit hyperactivity and comorbid disorders

J. Perel, W. B. Daviss, Raymond J. Pan, 2003, Expert review of neurotherapeutics.

Pharmacologic evidence to support clinical decision making for peripartum methadone treatment

B. Hanusa, M. Romkes, D. Bogen, 2012, Psychopharmacology.

A trial of buspirone for the control of disruptive behaviors in community‐dwelling patients with dementia

L. Burgio, R. Sweet, J. Janosky, 1994 .

Platelet membrane fluidity and treatment response in cognitively-impaired, depressed elderly: initial results

C. Reynolds, G. Zubenko, J. Perel, 2004, Psychopharmacology.

A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.

J. Perel, P. Dayton, M. M. Snell, 1964, Biochemical pharmacology.

The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.

D. Kupfer, B. Pollock, J. Perel, 1990, The Journal of clinical psychiatry.

2nd Year Maintenance and Discontinuation of Imipramine in Panic Disorder With Agoraphobia

M. Mavissakalian, J. Perel, 2001 .

Pharmacological factors of methylphenidate metabolism in behaviorally disordered children.

B. Winsberg, J. Perel, B. Hungund, 1980, Psychopharmacology bulletin.

Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detection.

B. Mulsant, J. Perel, D. Sorisio, 1995, Journal of chromatography. B, Biomedical applications.

Growth hormone secretion in children and adolescents at high risk for major depressive disorder.

R. Dahl, N. Ryan, D. Williamson, 2000, Archives of general psychiatry.

Efficacy of phenelzine and haloperidol in borderline personality disorder.

R. Ulrich, J. Cornelius, P. Soloff, 1993, Archives of general psychiatry.

A preliminary trial of fluoxetine in refractory borderline patients.

R. Ulrich, J. Cornelius, P. Soloff, 1991, Journal of clinical psychopharmacology.

Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.

R. Ulrich, J. Cornelius, P. Soloff, 1993, The American journal of psychiatry.

Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.

B. Pollock, C. Reynolds, E. Frank, 1992, The American journal of psychiatry.

Circadian patterns of cortisol, prolactin, and growth hormonal secretion during bingeing and vomiting in normal weight bulimic patients

L. Hsu, W. Kaye, T. Weltzin, 1991, Biological Psychiatry.

The effect of l-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients

D. Dunner, J. Perel, S. Heiber, 1977, Psychopharmacology.

Plasma and cerebrospinal fluid probenecid concentrations as related to accumulation of acidic biogenic amine metabolites in man

D. Dunner, M. Levitt, J. Perel, 1974, Psychopharmacologia.

CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION

J. Bigger, M. Davies, A. Glassman, 1979, The Lancet.

Compliance during tricyclic antidepressant therapy: pharmacokinetic and analytical issues.

J. Perel, 1988, Clinical chemistry.

Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patients.

P. Houck, H. Schulberg, Charlotte Brown, 1999, Journal of affective disorders.

Dose Ranging and Plasma Level-Response Relationships

M. Mavissakalian, J. Perel, 1995 .

Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.

M. Mavissakalian, J. Perel, 1989, Archives of general psychiatry.

Parent-child bonding and family functioning in depressed children and children at high risk and low risk for future depression.

R. Dahl, N. Ryan, D. Williamson, 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.

S. Schulz, J. Perel, E. Kahn, 1990, Journal of clinical psychopharmacology.

Decreased cortisol levels in adolescent girls with conduct disorder.

R. Rubin, W. Gardner, K. Pajer, 2001, Archives of general psychiatry.

Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children.

J. Sverd, B. Winsberg, J. Perel, 1980, Neuropediatrics.

Clomipramine and EEG sleep in depression

D. Kupfer, B. Pollock, C. Ehlers, 1989, Psychiatry Research.

Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders Correlation with increased serotonergic responsivity

T. Cooper, J. Mann, J. Perel, 1994, Biological Psychiatry.

Positron Emission Tomographic Imaging of Serotonin Activation Effects on Prefrontal Cortex in Healthy Volunteers

Thomas E. Nichols, M. Mintun, J. Mann, 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity.

F. Sallee, R. Stiller, J. Perel, 1992, Journal of the American Academy of Child and Adolescent Psychiatry.

Studies with phenylbutazone, oxyphenbutazone, and para-paradichloro phenylbutazone in horses.

J. Perel, M. Weiner, P. Dayton, 1969, The Cornell veterinarian.

Clomipramine in Obsessive‐Compulsive Disorder: Clinical Response and Plasma Levels

S. Olson, M. Mavissakalian, J. Perel, 1990, Journal of clinical psychopharmacology.

Psychopharmacologic treatment during pregnancy and lactation.

K. Wisner, J. Perel, Wisner Kl, 1996 .

Pharmacokinetically and clinician-determined adherence to an antidepressant regimen and clinical outcome in the TORDIA trial.

N. Ryan, B. Birmaher, M. Keller, 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

Postpartum Depression: A Randomized Trial of Sertraline Versus Nortriptyline

B. Hanusa, R. Findling, K. Wisner, 2006, Journal of clinical psychopharmacology.

Sertraline and norsertraline levels in three breastfed infants.

J. Perel, O. Mammen, G. Rudolph, 1997, The Journal of clinical psychiatry.

Imipramine in the treatment of agoraphobia: dose-response relationships.

M. Mavissakalian, J. Perel, 1985, The American journal of psychiatry.

Targeting imipramine dose in children with depression

R. Stiller, J. Perel, Michael Rancurello, 1986, Clinical pharmacology and therapeutics.

The Relationship of Plasma Imipramine and N‐Desmethylimipramine to Improvement in Agoraphobia

L. Michelson, M. Mavissakalian, J. Perel, 1984, Psychopharmacology bulletin.

Stimulatory tests of growth hormone secretion in prepubertal major depression: depressed versus normal children.

R. Dahl, N. Ryan, D. Williamson, 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.

K. Wisner, J. Perel, D. Sit, 2008, The Journal of clinical psychiatry.

Imipramine and 2-hydroxyimipramine: comparative cardiotoxicity and pharmacokinetics in swine

B. Pollock, J. Perel, 2005, Psychopharmacology.

Longitudinal Analysis of Nortriptyline Side Effects in Elderly Depressed Patients

Mark D. Miller, B. Pollock, C. Reynolds, 1991, Journal of geriatric psychiatry and neurology.

Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients.

D. Kupfer, M. Thase, C. Reynolds, 1996, The American journal of psychiatry.

Understanding the response lag to tricyclics. I. Application of pulse-loading regimens with intravenous clomipramine.

D. Kupfer, B. Pollock, B. Brandom, 1986, Psychopharmacology bulletin.

Imipramine protein binding and pharmacokinetics in children.

B. Winsberg, J. Perel, M. Hurwic, 1974, Advances in biochemical psychopharmacology.

THE METABOLISM OF PROBENECID IN MAN *

J. Perel, P. Dayton, James M. Perel, 1971, Annals of the New York Academy of Sciences.

Application of sleep investigations in understanding antidepressant drug — clinical drug interactions

D. Kupfer, J. Perel, 1983 .

Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.

M. Thase, I. Salloum, D. Daley, 2000, Addictive behaviors.

Fluoxetine trial in borderline personality disorder.

R. Ulrich, J. Cornelius, P. Soloff, 1990, Psychopharmacology bulletin.

Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.

M. Mavissakalian, J. Perel, Perel Jm, 1992, The American journal of psychiatry.

Reply to Drs Henderson and Vale [19]

B. Hanusa, K. Wisner, E. Moses-Kolko, 2007 .

Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response.

D. Kupfer, C. Reynolds, E. Frank, 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

S-mephenytoin 4-hydroxylation in older Americans

C. Reynolds, B. Pollock, J. Perel, 2004, European Journal of Clinical Pharmacology.

Serum clomipramine and metabolite levels in four nursing mother-infant pairs.

K. Wisner, J. Perel, J. Foglia, 1995, The Journal of clinical psychiatry.

2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.

M. Mavissakalian, J. Perel, 2001, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Timing of depression recurrence in the first year after birth.

B. Hanusa, K. Wisner, J. Perel, 2004, Journal of affective disorders.

Does recruitment method make a difference? Effects on protocol retention and treatment outcome in elderly depressed patients

D. Kupfer, C. Reynolds, E. Frank, 1995, Psychiatry Research.

Effect of pulse loading with clomipramine on EEG sleep

B. Pollock, C. Ehlers, J. Miewald, 1994, Psychiatry Research.

Early response patterns associated with successful clomipramine treatment.

D. Kupfer, B. Pollock, J. Miewald, 1993, Journal of clinical psychopharmacology.

Does lorazepam impair the antidepressant response to nortriptyline and psychotherapy?

Daniel J Buysse, D. Kupfer, C. Reynolds, 1997, The Journal of clinical psychiatry.

Changes in sleep quality, but not hormones predict time to postpartum depression recurrence.

S. Wisniewski, A. Prather, K. Wisner, 2011, Journal of affective disorders.

Serum nortriptyline levels in nursing mothers and their infants.

K. Wisner, J. Perel, 1991, The American journal of psychiatry.

Hydroxy metabolites of tricyclic antidepressants: evaluation of relative cardiotoxicity.

B. Pollock, J. Perel, B. Pollock, 1989, Psychopharmacology series.

Open-trial maintenance pharmacotherapy in late-life depression: Survival analysis

C. Reynolds, E. Frank, S. Imber, 1989, Psychiatry Research.

Plasma Haloperidol and Clinical Response: A Role for Reduced Haloperidol in Antipsychotic Activity?

R. Stiller, J. Perel, S. Curran, 1987, Journal of clinical psychopharmacology.

Antidepressants and EEG sleep: search for specificity.

D. Kupfer, B. Pollock, D. Spiker, 1987, Psychopharmacology series.

Metabolic and physiologic consequences of nortriptyline treatment in the elderly.

C. Reynolds, B. Pollock, C. Paradis, 1994, Psychopharmacology bulletin.

Determination of imipramine, desipramine and their hydroxy metabolites by reversed-phase chromatography with ultraviolet and coulometric detection.

J. Perel, D. Sorisio, J. Foglia, 1991, Journal of chromatography.

Biology, Therapeutics, and Prophylaxis in Recurrent Depression

D. Kupfer, E. Frank, J. Perel, 1986 .

Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed Patients.

Mark D. Miller, D. Kupfer, B. Pollock, 1995, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Nortriptyline and weight change in depressed patients over 60.

B. Pollock, C. Reynolds, S. Mazumdar, 1992, Journal of clinical psychopharmacology.

Nighttime ACTH, cortisol, prolactin, and growth hormone secretion in prepubertal depression

R. Dahl, N. Ryan, D. Williamson, 1995, Biological Psychiatry.

424. Antidepressant response to oral pulse loading with clomipramine

D. Kupfer, J. Miewald, S. Dubé, 1996, Biological Psychiatry.

Discrimination of recovery in the treatment of elderly patients with recurrent major depression: Limits of prediction

Mark D. Miller, Daniel J Buysse, D. Kupfer, 1994 .

Rapid-cycling affective disorders during imipramine treatment: a case report.

S. Siris, J. Perel, H. R. Chertoff, 1979, American Journal of Psychiatry.

The effects of fenfluramine on sleep and prolactin in depressed inpatients: A comparison of potential indices of brain serotonergic responsivity

Daniel J Buysse, M. Thase, J. Mann, 1993, Biological Psychiatry.

Treatment of consecutive episodes of major depression in the elderly.

B. Pollock, C. Reynolds, E. Frank, 1994, The American journal of psychiatry.

Platelet MAO in borderline personality disorder

J. Cornelius, P. Soloff, J. Perel, 1991, Biological Psychiatry.

The role of stereochemistry and chiral pharmacology in psychotropic drug development

R. Rivas-Vazquez, J. Perel, 2003 .

Debrisoquine hydroxylation phenotyping in geriatric psychopharmacology.

B. Pollock, C. Reynolds, P. Houck, 1992, Psychopharmacology bulletin.

Sertraline Prevents Postpartum Depression

B. Hanusa, K. Wisner, J. Perel, 2003 .

Serum fluvoxamine levels in breastfed infants.

K. Wisner, J. Perel, K. Peindl, 2001, The Journal of clinical psychiatry.

Protective effects of imipramine maintenance in panic disorder with agoraphobia

M. Mavissakalian, J. Perel, 1992, European Neuropsychopharmacology.

Plasma levels of imipramine in depression. Environmental and genetic factors.

J. Mendlewicz, A. Glassman, J. Perel, 1976, Neuropsychobiology.

Diagnosis and Treatment of Depression in Late Life

Mark E. Williams, W. H. Hall, B. Lebowitz, 1992 .

Pharmacologic evidence to support clinical decision making for peripartum methadone treatment

B. Hanusa, M. Romkes, D. Bogen, 2012, Psychopharmacology.

Psychiatric Disorders in Obstetrics.

M. Altemus, D. Bogen, K. Wisner, 2007 .

The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.

S. Olson, M. Mavissakalian, J. Perel, 1990, Psychopharmacology bulletin.

Plasma levels of imipramine and clinical outcome.

A. Glassman, J. Perel, S. Kantor, 1975, Psychopharmacology bulletin.

Intravenous pulse loading of clomipramine in adolescents with depression.

N. Ryan, F. Sallee, B. Pollock, 1989, Psychopharmacology bulletin.

Dopaminergic factors in human prolactin regulation: A pituitary model for the study of a neuroendocrine system in man

J. Perel, G. Langer, E. Sachar, 1979, Psychopharmacology.

Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.

D. Janowsky, E. Munson, J. Perel, 1984, The Journal of clinical psychiatry.

The Pharmacological Treatment of Delusional Depression: Part II

R. Dealy, D. Spiker, P. Soloff, 1986, Journal of clinical psychopharmacology.

Gastrointestinal distress to serotonergic challenge: a risk marker for emotional disorder?

R. Dahl, N. Ryan, D. Williamson, 2003, Journal of the American Academy of Child and Adolescent Psychiatry.

Pharmacokinetics of psychotropic drugs: What can it tell us?

P. Hrdina, Y. Lapierre, L. Hutchinson, 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Compliance duringTricyclic Antidepressant Therapy:Pharmacokinetic andAnalytical Issues

J. Perel, 1988 .

GTP-cyclohydrolase deficiency responsive to sapropterin and 5-HTP supplementation: relief of treatment-refractory depression and suicidal behaviour

J. Vockley, D. Brent, Marianne Mcguire, 2011, BMJ Case Reports.

Effect of Alosetron (a New 5‐HT3 Receptor Antagonist) on the Pharmacokinetics of Haloperidol in Schizophrenic Patients

A. Metz, J. Perel, R. Kunka, 1995, Journal of clinical pharmacology.

Comparative neurotransmitter reuptake and anticholinergic potencies of the 8-hydroxy metabolites of clomipramine.

J. Perel, R. Núñez, 1995, Psychopharmacology bulletin.

Imipramine treatment of prepubertal major depressive disorders: plasma levels and clinical response--preliminary report.

J. Perel, J. Puig-Antich, W. Chambers, 1980, Psychopharmacology bulletin.

Estimated infant exposure to enantiomer-specific methadone levels in breastmilk.

B. Hanusa, Matthew J. Thompson, D. Bogen, 2011, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.

R. Ulrich, P. Soloff, J. Perel, 1986, Psychopharmacology bulletin.

Comparative cardiotoxicity of nortriptyline and its isomeric 10-hydroxymetabolites.

B. Pollock, J. Perel, G. Everett, 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Pharmacodynamics of imipramine in depressed patients.

J. Perel, M. Kanzler, M. Hurwic, 1975, Psychopharmacology bulletin.

Childhood and adolescent depression: a review of the past 10 years. Part I.

N. Ryan, D. Williamson, B. Birmaher, 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

Chronic Medical Illness in Patients With Recurrent Major Depression.

B. Pollock, E. Frank, P. Houck, 1996, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression.

D. Kupfer, M. Thase, E. Frank, 1992, Psychopharmacology bulletin.

Rapid achievement of antidepressant effect with intravenous chlorimipramine.

B. Pollock, J. Perel, M. Shostak, 1985, The New England journal of medicine.

Kava-induced fulminant hepatic failure.

G. Mazariegos, J. Reyes, J. Campo, 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

Serotonergic functioning in depressed abused children: clinical and familial correlates

R. Dahl, N. Ryan, B. Birmaher, 1998, Biological Psychiatry.